Pub Date : 2016-12-01DOI: 10.1136/jfprhc-2015-101375
C. Iltemir Duvan, Y. Onaran, E. Aktepe Keskin, E. Yüce, B. Yanık, H. Kafalı, Nilgun Ozturk Turhan
Aim To evaluate the effects of the etonogestrel contraceptive implant (Implanon®) on bone metabolism in lactating women using markers for bone formation and resorption. Study design This single-centre, prospective cohort study was conducted in Turgut Ozal University Medical Faculty Obstetrics and Gynecology Department with healthy lactating women aged between 24 and 38 years to compare the effect on bone metabolism of 6 months’ use of either the implant or a non-hormonal contraceptive method. The study group (n=25) used an implant and the control group (n=25) used a non-hormonal contraceptive intrauterine device inserted 40 days’ postpartum. Bone metabolism differences at the time of insertion and after 6 months were assessed quantitatively by biochemical analysis of serum and urine samples. Results At baseline, serum levels of bone metabolism parameters were similar for the two groups. In the implant group, serum alkaline phosphatase (ALP) levels decreased (p=0.004) and total protein levels increased (p=0.045) at 6 months. In the control group, serum levels of bone metabolism parameters did not change at 6 months compared to baseline. However, serum levels of phosphorus (p=0.013) and ALP (p=0.003) decreased at 6 months compared to baseline. Conclusion Six months’ postpartum use of Implanon was found to have no deleterious impact on bone turnover in healthy lactating women.
{"title":"Effects of the etonogestrel contraceptive implant (Implanon®) on bone metabolism during lactation: a prospective study","authors":"C. Iltemir Duvan, Y. Onaran, E. Aktepe Keskin, E. Yüce, B. Yanık, H. Kafalı, Nilgun Ozturk Turhan","doi":"10.1136/jfprhc-2015-101375","DOIUrl":"https://doi.org/10.1136/jfprhc-2015-101375","url":null,"abstract":"Aim To evaluate the effects of the etonogestrel contraceptive implant (Implanon®) on bone metabolism in lactating women using markers for bone formation and resorption. Study design This single-centre, prospective cohort study was conducted in Turgut Ozal University Medical Faculty Obstetrics and Gynecology Department with healthy lactating women aged between 24 and 38 years to compare the effect on bone metabolism of 6 months’ use of either the implant or a non-hormonal contraceptive method. The study group (n=25) used an implant and the control group (n=25) used a non-hormonal contraceptive intrauterine device inserted 40 days’ postpartum. Bone metabolism differences at the time of insertion and after 6 months were assessed quantitatively by biochemical analysis of serum and urine samples. Results At baseline, serum levels of bone metabolism parameters were similar for the two groups. In the implant group, serum alkaline phosphatase (ALP) levels decreased (p=0.004) and total protein levels increased (p=0.045) at 6 months. In the control group, serum levels of bone metabolism parameters did not change at 6 months compared to baseline. However, serum levels of phosphorus (p=0.013) and ALP (p=0.003) decreased at 6 months compared to baseline. Conclusion Six months’ postpartum use of Implanon was found to have no deleterious impact on bone turnover in healthy lactating women.","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"25 1","pages":"113 - 117"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2015-101375","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63793473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-29DOI: 10.1136/jfprhc-2016-101656
D. Horwell
I was very interested to read Speedie et al .'s report1 on their carefully conducted randomised trial of two stabilising forceps for the insertion of intrauterine contraception (IUC). Their finding that there is no significant difference in the pain experienced on application of single-toothed volsellum forceps and Littlewood forceps in the specific group of women selected, those with at least one vaginal delivery, is interesting, and was certainly worth establishing objectively. However, I was disappointed that the instrument selected by them as the comparator for the obviously ‘traumatic’ single-toothed volsellum was the Littlewood forceps rather than a commonly-used alternative, the Judd-Allis forceps. The Judd-Allis forceps (Figure 1A) is a lengthened form of the Allis forceps that …
{"title":"Cervical grasping and stabilising forceps","authors":"D. Horwell","doi":"10.1136/jfprhc-2016-101656","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101656","url":null,"abstract":"I was very interested to read Speedie et al .'s report1 on their carefully conducted randomised trial of two stabilising forceps for the insertion of intrauterine contraception (IUC). Their finding that there is no significant difference in the pain experienced on application of single-toothed volsellum forceps and Littlewood forceps in the specific group of women selected, those with at least one vaginal delivery, is interesting, and was certainly worth establishing objectively. However, I was disappointed that the instrument selected by them as the comparator for the obviously ‘traumatic’ single-toothed volsellum was the Littlewood forceps rather than a commonly-used alternative, the Judd-Allis forceps.\u0000\u0000The Judd-Allis forceps (Figure 1A) is a lengthened form of the Allis forceps that …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"77 - 77"},"PeriodicalIF":0.0,"publicationDate":"2016-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101656","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63794383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-29DOI: 10.1136/jfprhc-2016-101621
Angela Bussey, K. French
A patient group direction (PGD) is a legal mechanism1 that allows the supply and/or administration of a specified medicine or medicines, by named authorised health professionals, to a well-defined group of patients requiring treatment for the condition described in the PGD without the need for a prescription or an instruction from a prescriber. Using a PGD is not a form of prescribing.2 Whilst prescribing remains the preferred option for the majority of care,2 sexual health services have been dependent on this legal mechanism to supply and administer medicines in the absence of timely access to a prescriber for many years. For example, medicines may be supplied by registered nurses or pharmacists to people attending for contraception or for other unscheduled care in a sexual health clinic or in a community pharmacy for a discrete treatment episode, such as emergency contraception or treatment for chlamydia. Whilst nurses and pharmacists may now train to become independent non-medical prescribers in their own right, many services still rely on PGDs to deliver the service. Prior to 2011, contraceptive and sexual health service providers in London developed their own PGDs. It became apparent from discussions with lead nurses and doctors within the services that there were problems due to the many different versions being used and the human resource needed to develop/review PGDs on a regular basis. There was a risk of inconsistent standards of care and risks associated with practice where nurses employed in more than one organisation had to work to different PGDs. At that time, it was calculated that there were at least 30 versions of each PGD. …
{"title":"A pan-London approach to patient group directions in sexual health services: from aspiration to reality","authors":"Angela Bussey, K. French","doi":"10.1136/jfprhc-2016-101621","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101621","url":null,"abstract":"A patient group direction (PGD) is a legal mechanism1 that allows the supply and/or administration of a specified medicine or medicines, by named authorised health professionals, to a well-defined group of patients requiring treatment for the condition described in the PGD without the need for a prescription or an instruction from a prescriber. Using a PGD is not a form of prescribing.2\u0000\u0000Whilst prescribing remains the preferred option for the majority of care,2 sexual health services have been dependent on this legal mechanism to supply and administer medicines in the absence of timely access to a prescriber for many years.\u0000\u0000For example, medicines may be supplied by registered nurses or pharmacists to people attending for contraception or for other unscheduled care in a sexual health clinic or in a community pharmacy for a discrete treatment episode, such as emergency contraception or treatment for chlamydia.\u0000\u0000Whilst nurses and pharmacists may now train to become independent non-medical prescribers in their own right, many services still rely on PGDs to deliver the service.\u0000\u0000Prior to 2011, contraceptive and sexual health service providers in London developed their own PGDs. It became apparent from discussions with lead nurses and doctors within the services that there were problems due to the many different versions being used and the human resource needed to develop/review PGDs on a regular basis. There was a risk of inconsistent standards of care and risks associated with practice where nurses employed in more than one organisation had to work to different PGDs. At that time, it was calculated that there were at least 30 versions of each PGD. …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"154 - 156"},"PeriodicalIF":0.0,"publicationDate":"2016-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101621","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63794168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-29DOI: 10.1136/jfprhc-2016-101487
Lesley Hoggart, V. Newton, L. Bury
Background In recent years there has been growing international interest in identifying risk factors associated with ‘repeat abortion’, and developing public health initiatives that might reduce the rate. This article draws on a research study looking at young women's abortion experience in England and Wales. The study was commissioned with a specific focus on women who had undergone more than one abortion. We examine what may influence women's post-abortion reproductive behaviour, in addition to exploring abortion-related stigma, in the light of participants' own narratives. Study design Mixed-methods research study: a quantitative survey of 430 women aged 16–24 years, and in-depth qualitative interviews with 36 women who had undergone one or more abortions. This article focuses on the qualitative data from two subsets of young women: those we interviewed twice (n=17) and those who had experienced more than one unintended/unwanted pregnancy (n=15). Results The qualitative research findings demonstrate the complexity of women's contraceptive histories and reproductive lives, and thus the inherent difficulty of establishing causal patterns for more than one abortion, beyond the obvious observation that contraception was not used, or not used effectively. Women who had experienced more than one abortion did, however, express intensified abortion shame. Conclusions This article argues that categorising women who have an abortion in different ways depending on previous episodes is not helpful. It may also be damaging, and generate increased stigma, for women who have more than one abortion.
{"title":"‘Repeat abortion’, a phrase to be avoided? Qualitative insights into labelling and stigma","authors":"Lesley Hoggart, V. Newton, L. Bury","doi":"10.1136/jfprhc-2016-101487","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101487","url":null,"abstract":"Background In recent years there has been growing international interest in identifying risk factors associated with ‘repeat abortion’, and developing public health initiatives that might reduce the rate. This article draws on a research study looking at young women's abortion experience in England and Wales. The study was commissioned with a specific focus on women who had undergone more than one abortion. We examine what may influence women's post-abortion reproductive behaviour, in addition to exploring abortion-related stigma, in the light of participants' own narratives. Study design Mixed-methods research study: a quantitative survey of 430 women aged 16–24 years, and in-depth qualitative interviews with 36 women who had undergone one or more abortions. This article focuses on the qualitative data from two subsets of young women: those we interviewed twice (n=17) and those who had experienced more than one unintended/unwanted pregnancy (n=15). Results The qualitative research findings demonstrate the complexity of women's contraceptive histories and reproductive lives, and thus the inherent difficulty of establishing causal patterns for more than one abortion, beyond the obvious observation that contraception was not used, or not used effectively. Women who had experienced more than one abortion did, however, express intensified abortion shame. Conclusions This article argues that categorising women who have an abortion in different ways depending on previous episodes is not helpful. It may also be damaging, and generate increased stigma, for women who have more than one abortion.","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"26 - 30"},"PeriodicalIF":0.0,"publicationDate":"2016-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101487","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63793714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-28DOI: 10.1136/jfprhc-2016-101675
S. de Silva
Sue Lloyd-Roberts. London, UK: Simon & Schuster, 2016. ISBN-13: 978-1-471-15390-7. Price: £16.00. Pages: 320 (hardcover) Not long after the author's death (the journalist, Sue Lloyd-Roberts) in October 2015, I heard her daughter speaking about this book on Radio 4. The ideas behind the book, and its aim to report on the experiences of women worldwide, sounded compelling. However, I was apprehensive that reading the book would prove too disturbing. It is shocking, but also extraordinary, and I could not put it down. Sue Lloyd-Roberts writes transparently, based on the interviews that she conducted. Each chapter begins …
{"title":"The War on Women: And the Brave Ones Who Fight Back","authors":"S. de Silva","doi":"10.1136/jfprhc-2016-101675","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101675","url":null,"abstract":"Sue Lloyd-Roberts. London, UK: Simon & Schuster, 2016. ISBN-13: 978-1-471-15390-7. Price: £16.00. Pages: 320 (hardcover)\u0000\u0000Not long after the author's death (the journalist, Sue Lloyd-Roberts) in October 2015, I heard her daughter speaking about this book on Radio 4. The ideas behind the book, and its aim to report on the experiences of women worldwide, sounded compelling. However, I was apprehensive that reading the book would prove too disturbing. It is shocking, but also extraordinary, and I could not put it down.\u0000\u0000Sue Lloyd-Roberts writes transparently, based on the interviews that she conducted. Each chapter begins …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"83 - 83"},"PeriodicalIF":0.0,"publicationDate":"2016-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101675","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45515073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-25DOI: 10.1136/jfprhc-2016-101647
Tracey A. Wilkinson, Michelle R Berardi, Erin Crocker, Christina A Nordt, Michael Silverstein
Emergency contraception (EC) is a safe and effective form of pregnancy prevention after intercourse, but its efficacy decreases with time.1 ,2 Having EC in advance of need enables it to be taken soon after unprotected intercourse, thus maximising its effect. EC is available over-the-counter in the USA without age restrictions, but many clinicians provide EC in advance to their patients as a means of eliminating residual barriers to access.3–5 In a randomised pilot study among sexually active women in an urban adolescent clinic, we examined the feasibility of using text messages as a convenient mechanism to remind adolescents to fulfil their advance EC …
{"title":"Feasibility of using text message reminders to increase fulfilment of emergency contraception prescriptions by adolescents","authors":"Tracey A. Wilkinson, Michelle R Berardi, Erin Crocker, Christina A Nordt, Michael Silverstein","doi":"10.1136/jfprhc-2016-101647","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101647","url":null,"abstract":"Emergency contraception (EC) is a safe and effective form of pregnancy prevention after intercourse, but its efficacy decreases with time.1 ,2 Having EC in advance of need enables it to be taken soon after unprotected intercourse, thus maximising its effect. EC is available over-the-counter in the USA without age restrictions, but many clinicians provide EC in advance to their patients as a means of eliminating residual barriers to access.3–5\u0000\u0000In a randomised pilot study among sexually active women in an urban adolescent clinic, we examined the feasibility of using text messages as a convenient mechanism to remind adolescents to fulfil their advance EC …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"79 - 80"},"PeriodicalIF":0.0,"publicationDate":"2016-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101647","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63794374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-25DOI: 10.1136/jfprhc-2016-101438
D. Mansour
Since writing an editorial for this journal in 20141 I have been repeatedly asked about my views on postponing menstruation. Women in the 21st century want to avoid periods when on holiday yet have difficulty accepting highly effective, reversible forms of contraception which provide infrequent bleeding. Authors of a BMJ article published 16 years ago suggested that prescribing progestogens to delay periods was a lifestyle choice and should not be funded by the National Health Service.2 I am not sure I feel that strongly but I do think women need to know all options and any potential risks or side effects associated with each treatment – they may think twice. Only one drug is licensed to postpone menstruation in the UK and that is norethisterone. The Summary of Product Characteristics (SPC) state that at low dose’ (5 mg three times a day) norethisterone may be used to treat “metropathia haemorrhagica, premenstrual syndrome, postponement of menstruation, dysmenorrhoea, endometriosis and menorrhagia”.3 There is limited evidence to support these indications1 but it does delay the onset of …
{"title":"Postponing menstruation: choices and concerns","authors":"D. Mansour","doi":"10.1136/jfprhc-2016-101438","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101438","url":null,"abstract":"Since writing an editorial for this journal in 20141 I have been repeatedly asked about my views on postponing menstruation. Women in the 21st century want to avoid periods when on holiday yet have difficulty accepting highly effective, reversible forms of contraception which provide infrequent bleeding. Authors of a BMJ article published 16 years ago suggested that prescribing progestogens to delay periods was a lifestyle choice and should not be funded by the National Health Service.2 I am not sure I feel that strongly but I do think women need to know all options and any potential risks or side effects associated with each treatment – they may think twice.\u0000\u0000Only one drug is licensed to postpone menstruation in the UK and that is norethisterone. The Summary of Product Characteristics (SPC) state that at low dose’ (5 mg three times a day) norethisterone may be used to treat “metropathia haemorrhagica, premenstrual syndrome, postponement of menstruation, dysmenorrhoea, endometriosis and menorrhagia”.3 There is limited evidence to support these indications1 but it does delay the onset of …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"160 - 161"},"PeriodicalIF":0.0,"publicationDate":"2016-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101438","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63793837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-10-28DOI: 10.1136/jfprhc-2016-101623
A. Thwaites, L. Bacon, J. Dickson
In a letter1 published in the July 2016 issue of this journal, the Breastfeeding Network's approach to postpartum contraception was advocated and described as: (i) avoidance of all hormonal contraception in the first 21 days postpartum; (ii) after that, a month's trial of the “mini-pill” to check milk supply is unaffected; and (iii) initiation of hormonal long-acting reversible contraception (LARC) methods (e.g. the subdermal implant), after this and only if breastfeeding is going well. The letter expresses concern among breastfeeding counsellors, based solely on anecdotal reports, regarding “the impact of hormonal contraception on milk supply” (including progestogen-only methods). The Breastfeeding Network's ‘Breastfeeding and Contraception’ factsheet2 asserts that initiation too early after delivery “may interfere with priming of prolactin receptors” and refers to anecdotal reports …
{"title":"Breastfeeding and postpartum contraception: dual priorities in the immediate postnatal period","authors":"A. Thwaites, L. Bacon, J. Dickson","doi":"10.1136/jfprhc-2016-101623","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101623","url":null,"abstract":"In a letter1 published in the July 2016 issue of this journal, the Breastfeeding Network's approach to postpartum contraception was advocated and described as: (i) avoidance of all hormonal contraception in the first 21 days postpartum; (ii) after that, a month's trial of the “mini-pill” to check milk supply is unaffected; and (iii) initiation of hormonal long-acting reversible contraception (LARC) methods (e.g. the subdermal implant), after this and only if breastfeeding is going well. The letter expresses concern among breastfeeding counsellors, based solely on anecdotal reports, regarding “the impact of hormonal contraception on milk supply” (including progestogen-only methods). The Breastfeeding Network's ‘Breastfeeding and Contraception’ factsheet2 asserts that initiation too early after delivery “may interfere with priming of prolactin receptors” and refers to anecdotal reports …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"163 - 164"},"PeriodicalIF":0.0,"publicationDate":"2016-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101623","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63794224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-10-14DOI: 10.1136/jfprhc-2016-101638
S. Quilliam
Emily Nagoski. London, UK: Scribe Publications, 2015. ISBN-13: 978-1-925-22801-4. Price: £12.99. Pages: 432 (paperback) There are now literally thousands of books – my own among them – which aim to help women understand and make the most of their sexuality. This book, however, is special. Written by Emily Nagoski, formerly Director of Wellness Education at Smith College (Massachusetts, USA) and the Kinsey Institute (Indiana, USA), the book rises above most others for many reasons. The first is its range: the 400+ pages cover not only female physiology, sexual response, and ‘what to do in bed’, but also the emotional and relational underpinnings of sexuality; its social context; its pitfalls, its pleasures. A full set by any count and, as the book's cover claims, …
{"title":"Come As You Are: The Surprising New Science That Will Transform Your Sex Life","authors":"S. Quilliam","doi":"10.1136/jfprhc-2016-101638","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101638","url":null,"abstract":"Emily Nagoski. London, UK: Scribe Publications, 2015. ISBN-13: 978-1-925-22801-4. Price: £12.99. Pages: 432 (paperback)\u0000\u0000There are now literally thousands of books – my own among them – which aim to help women understand and make the most of their sexuality. This book, however, is special.\u0000\u0000Written by Emily Nagoski, formerly Director of Wellness Education at Smith College (Massachusetts, USA) and the Kinsey Institute (Indiana, USA), the book rises above most others for many reasons.\u0000\u0000The first is its range: the 400+ pages cover not only female physiology, sexual response, and ‘what to do in bed’, but also the emotional and relational underpinnings of sexuality; its social context; its pitfalls, its pleasures. A full set by any count and, as the book's cover claims, …","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"43 1","pages":"156 - 156"},"PeriodicalIF":0.0,"publicationDate":"2016-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101638","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63794336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-10-01DOI: 10.1136/jfprhc-2016-101624
{"title":"Elizabeth (Libby) Wilson 1926-2016.","authors":"","doi":"10.1136/jfprhc-2016-101624","DOIUrl":"https://doi.org/10.1136/jfprhc-2016-101624","url":null,"abstract":"","PeriodicalId":15734,"journal":{"name":"Journal of Family Planning and Reproductive Health Care","volume":"42 4","pages":"301"},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jfprhc-2016-101624","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35642910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：